Identification of potent natural compounds in targeting Leishmania major CYP51 and GP63 proteins using a high-throughput computationally enhanced screening
Abstract Background Leishmaniasis is a disease caused by protozoan forms called Leishmania which infect animals and humans. The drugs have been in use since half a century due to which there have been mutations in the microbe-facilitating drug resistance. So this provides a reason for searching for...
Saved in:
Main Authors: | Deepak A. Yaraguppi (Author), Sanjay H. Deshpande (Author), Zabin K. Bagewadi (Author), Uday Muddapur (Author), Sushil Anand (Author), Santosh B. Patil (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2020-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Variation in Leishmania chemokine suppression driven by diversification of the GP63 virulence factor
by: Alejandro L. Antonia, et al.
Published: (2021) -
Variation in Leishmania chemokine suppression driven by diversification of the GP63 virulence factor.
by: Alejandro L Antonia, et al.
Published: (2021) -
Diverse inhibitor chemotypes targeting Trypanosoma cruzi CYP51.
by: Shamila S Gunatilleke, et al.
Published: (2012) -
Identification of potent chemotypes targeting Leishmania major using a high-throughput, low-stringency, computationally enhanced, small molecule screen.
by: Elizabeth R Sharlow, et al.
Published: (2009) -
Trypanosoma brucei CYP51: Essentiality and Targeting Therapy in an Experimental Model.
by: Frédéric-Antoine Dauchy, et al.
Published: (2016)